GE Healthcare and Volta Medical enter a joint development agreement for AI-driven electrophysiology technologies

image credit- shutterstock

Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists, announced a Joint Development Agreement with GE HealthCare. Through this collaboration, Volta aims to integrate its latest AI solution, the Volta AF-Xplorer, with GE HealthCare’s latest digital platform, Prucka 3 and CardioLab EP Recording system. The combined solutions are expected to enhance performance and streamline workflows for electrophysiologists during catheter ablation procedures to treat atrial fibrillation (AFib).  

Volta Medical’s AI solution is designed to assist electrophysiologists in real-time assessment of dispersed electrograms (EGMs). This aligns with GE HealthCare's CardioLab EP Recording system’s signal clarity. In bringing these technologies together, the companies aim to help physicians optimize the management of AFib by integrating advanced EP recording capabilities with AI-driven dispersion information.

The company is now focusing on early commercialization efforts and the completion of the RESTART clinical trial, which is evaluating the use of Volta’s AI ablation solution in recurrent-AFib patients who failed previous ablations and are now undergoing Volta-supported ablation.